Airway Management Receives FDA Clearance for Digitally Printed Sleep Apnea Device

by Medical

U.S.-based medical device company Airway Management has received FDA clearance for the Nylon flexTAP, described as the world’s first digitally printed single-point midline oral appliance for sleep apnea. The device, manufactured in the U.S., combines the company’s patented Vertex Technology with a design intended for patients with mild to moderate obstructive sleep apnea (OSA). By using digital printing, the Nylon flexTAP enables a custom fit without requiring bite registration, which can simplify the fitting process for clinicians and patients.

Texas A&M Researcher Advances 3D Printed Medications for Children

by Medical

Dr. Mansoor Khan, researcher of Texas A&M University is advancing the use of 3D printing to produce medications tailored for children, addressing long-standing challenges in pediatric dosing. By creating dose-flexible tablets, his approach ensures that children receive the exact amount of medication required for their age and weight, eliminating the need for pharmacists to manipulate adult pills, a process that can result in imprecise dosages.

UTS Researchers Advance Study of Preeclampsia With Bioprinted Placentas

by Medical

Researchers at the University of Technology Sydney (UTS) have successfully 3D bioprinted miniature placentas, opening a new path for investigating pregnancy complications. The study, published in Nature Communications and led by Associate Professor Lana McClements with first author Dr Claire Richards, highlights the potential of this technology in addressing conditions such as preeclampsia, which affects 5–8% of pregnancies and contributes to global maternal and infant mortality.